SYS ONLINE
Supplements/Compound

Ergothioneine (Extra)

Unique thiol antioxidant concentrated in mitochondria via OCTN1.

Buy

Overview

Unique thiol antioxidant concentrated in mitochondria via OCTN1.

Natural sources
  • Endogenously produced or biosynthesized molecule
  • Standardized pharmaceutical- or food-grade supplement
  • Combined with cofactors that improve absorption or activity
Common forms
  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Forms & variants of Ergothioneine

Different chemical forms of Ergothioneine behave differently. Browse each form's mechanism, bioavailability, and best-use context.

Mechanism of action

Selective transport into oxidatively stressed cells; scavenges hydroxyl radicals.

Pathways
  • · Selective transport into oxidatively stressed cells
  • · scavenges hydroxyl radicals

Effects on the body

Supports
Inverse association with cognitive decline

Organ system effects

Brain & CNS

Ergothioneine (Extra) acts on hallmarks of aging including oxidative stress, mitochondrial dysfunction, and senescence signaling.

Evidence-based benefits

Inverse association with cognitive decline

Limited evidence

Potential side effects

Common
  • · Ergothioneine (Extra) is generally well-tolerated at evidence-based doses
  • · Mild GI discomfort (nausea, loose stools, or bloating) possible at higher intakes
  • · Headache or transient fatigue reported by a small fraction of users
Rare
  • · Allergic or hypersensitivity reaction (rash, itching, swelling)
  • · Sleep disturbance if taken late in the day
Serious
  • · Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing

Drug interactions

Prescription medications (general)
Always disclose Ergothioneine (Extra) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
minor

Supplement interactions

Pairs well with
  • NAD+ precursor (NMN or NR)
    Complementary mitochondrial and sirtuin support.
  • Omega-3
    Lowers inflammation and supports membrane integrity.
  • Omega-3 (EPA/DHA)
    Membrane fluidity and neuronal signaling support.
Avoid combining with

No specific avoidances listed.

Dosing & bioavailability

Typical dose
5–25 mg
Best form
Most evidence is based on the capsule or softgel form.
Timing
Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
With food?
Either

Where to buy

Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

Scientific evidence8Show studies
CohortHeliyon · 2020

Ergothioneine and frailty

Beelman RB, et al.

Observational study in elderly.

Key findings

Low ergothioneine correlated with frailty and cognitive decline.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — Inverse association with cognitive decline

Live PubMed search

Live results for "Ergothioneine (Extra) Inverse association with cognitive decline" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "Inverse association with cognitive decline". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — randomized controlled trial

Live PubMed search

Live results for "Ergothioneine (Extra) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — meta-analysis

Live PubMed search

Live results for "Ergothioneine (Extra) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — pharmacokinetics

Live PubMed search

Live results for "Ergothioneine (Extra) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — safety adverse events

Live PubMed search

Live results for "Ergothioneine (Extra) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: Ergothioneine (Extra) — dose response

Live PubMed search

Live results for "Ergothioneine (Extra) dose response" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Ergothioneine (Extra) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewGoogle Scholar · 1970

Google Scholar: Ergothioneine (Extra) — clinical evidence

Live Scholar search

Cross-database citation index for Ergothioneine (Extra) as it relates to "clinical evidence".

Key findings

Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

Open study
Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

Community discussion

(0 threads)

Share your experience or read what others have tried. Anecdotes are not medical advice.

Sign in or create a free account to post or reply.
Loading discussion…